SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-015863
Filing Date
2021-08-05
Accepted
2021-08-05 16:15:49
Documents
79
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q auph-20210630.htm   iXBRL 10-Q 1204337
2 EX-31.1 auph-2021q2exx311.htm EX-31.1 10971
3 EX-31.2 auph-2021q2exx312.htm EX-31.2 11113
4 EX-32.1 auph-2021q2exx321.htm EX-32.1 5438
5 EX-32.2 auph-2021q2exx322.htm EX-32.2 5446
  Complete submission text file 0001628280-21-015863.txt   5890605

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT auph-20210630.xsd EX-101.SCH 38954
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT auph-20210630_cal.xml EX-101.CAL 67356
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT auph-20210630_def.xml EX-101.DEF 158804
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT auph-20210630_lab.xml EX-101.LAB 492652
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT auph-20210630_pre.xml EX-101.PRE 317904
11 EXTRACTED XBRL INSTANCE DOCUMENT auph-20210630_htm.xml XML 1008491
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36421 | Film No.: 211148387
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences